Wulf John William

SEC Form 4 insider trading activity

Wulf John William has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.

On the most recent filing, Wulf John William is listed as Director at agilon health, inc. Inside the rolling window, Wulf John William reported 1 open-market purchase totaling $51K in AGL and no open-market sales.

Companies traded

Other insiders at AGL

Insider Buying

$51K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
AGLPurchase$51KJan 30SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Wulf John William made?

Wulf John William has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Wulf John William trade?

Wulf John William has filed SEC Form 4 disclosures for 1 company, including AGL.

When was Wulf John William's most recent SEC Form 4 filing?

Wulf John William's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.

What is Wulf John William's total buy and sell value in the current window?

Inside the rolling retention window, Wulf John William bought $51K and sold $0 based on SEC Form 4 filings.

What was Wulf John William's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 81,000 AGL shares on 2025-11-12, worth $51K, per SEC Form 4 filings.